|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 519/00 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| C07K 5/062 | (2006.01) |
| (11) | Number of the document | 3612537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18718452.8 |
| Date of filing the European patent application | 2018-04-18 | |
| (97) | Date of publication of the European application | 2020-02-26 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-13 |
| (46) | Date of publication of the claims translation | 2022-10-10 |
| (86) | Number | PCT/EP2018/059846 |
| Date | 2018-04-18 |
| (87) | Number | WO 2018/192944 |
| Date | 2018-10-25 |
| (30) | Number | Date | Country code |
| 201706133 | 2017-04-18 | GB | |
| 201721337 | 2017-12-19 | GB |
| (72) |
HOWARD, Philip Wilson , GB
GREGSON, Stephen John , GB
|
| (73) |
Medimmune Limited ,
Milstein Building
Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolobenzodiazepino konjugatai |
| PYRROLOBENZODIAZEPINE CONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 9 | 208.00 EUR |
| 2027-04-18 |